Presentation TCT 2019 COAPT, Partner 2, and Evolut Low-Risk Trial Synopsis and What They Mean Moving Forward Presenter: Elizabeth Perpetua September 25, 2019
News Conference News TCT 2018 PORTICO I: Low 1-Year Mortality With Repositionable TAVR Valve in OUS Experience L.A. McKeown September 27, 2018
News Opinion Editor's Corner TCT 2018 TCT 2018, Day Two: COAPT Prompts Round of Applause, Plus New Valve Insights Shelley Wood September 23, 2018
News Conference News TCT 2018 SOLVE-TAVI: TAVR Equally Safe With Balloon-, Self-Expanding Valves and General, Local Anesthesia Yael L. Maxwell September 23, 2018
News Conference News TCT 2016 Sentinel Cerebral Protection Device in TAVR ‘Promising’ but Trial Misses Primary Endpoint Shelley Wood November 01, 2016
Presentation TCT 2016 Rationale for and Design of SAPIEN LOW RISK and EVOLUTE LOW RISK Presenter: Michael Argenziano, Alec S. Vahanian, Patrick T. O'Gara October 31, 2016
Presentation TCT 2016 Low-Risk Studies: Design and Updates III - The Evolut R Low-Risk Trial Presenter: Patrick T. O'Gara, Alec S. Vahanian, Jeffrey J. Popma October 30, 2016
News Conference News TCT 2014 Bioabsorbable Polymer DES Represent Evolution to Stenting Platform September 19, 2014
News Conference News TCT 2014 TCT Course Director Outlines Current TAVR Controversies September 14, 2014